These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4767765)

  • 1. Treatment of type II hyperlipoproteinaemia with cholestyramine.
    Schade RW; Laar A van't ; Jansen AP
    Neth J Med; 1973; 16(6):254-9. PubMed ID: 4767765
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cholestyramine therapy in type II hyperlipoproteinemia].
    Christensen NC; Mogensen EF
    Ugeskr Laeger; 1971 Dec; 133(49):2431-4. PubMed ID: 5136077
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperlipoproteinemias: significance--diagnosis--therapy].
    Schwandt P
    Internist (Berl); 1971 Nov; 12(11):481-7. PubMed ID: 4943880
    [No Abstract]   [Full Text] [Related]  

  • 4. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.
    Glueck CJ; Ford S; Scheel D; Steiner P
    JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholestyramine for elevated serum cholesterol.
    Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous form.
    Moutafis CD; Myant NB; Mancini M; Oriente P
    Atherosclerosis; 1971; 14(2):247-58. PubMed ID: 5165782
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
    Carlson LA; Olsson AG; Orö L; Rössner S
    Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
    [No Abstract]   [Full Text] [Related]  

  • 9. Fenofibrate and cholestyramine in type II hyperlipoproteinaemia.
    Lehtonen A; Viikari J
    Artery; 1982; 10(5):353-67. PubMed ID: 7181678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein lipid alterations with cholestyramine administration.
    Jones RJ; Dobrilovic L
    J Lab Clin Med; 1970 Jun; 75(6):953-66. PubMed ID: 5421080
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypolipidemic drugs and hyperlipoproteinemia.
    Levy RI; Langer T
    Ann N Y Acad Sci; 1971 Jul; 179():475-80. PubMed ID: 4941915
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined drug therapy for familial hypercholesterolemia.
    Packard CJ; Stewart JM; Morgan HG; Lorimer AR; Shepherd J
    Artery; 1980; 7(4):281-9. PubMed ID: 7213018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
    Glueck CJ; Tsang RC; Fallat RW; Scheel D
    Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of cholestyramine on the elimination of cholesterol as bile acids in patients with hyperlipoproteinaemia type II and IV.
    Einarsson K; Hellström K; Kallner M
    Eur J Clin Invest; 1974 Dec; 4(6):405-10. PubMed ID: 4442440
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipoproteins and hyperlipoproteinemias].
    Weisweiler P; Schwandt P
    Fortschr Med; 1980 Mar; 98(9):313-6. PubMed ID: 7372258
    [No Abstract]   [Full Text] [Related]  

  • 16. Correction of hyperlipoproteinaemia.
    Lancet; 1971 Feb; 1(7693):276-7. PubMed ID: 4100022
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of cholestyramine on lipoprotein metabolism in rat blood].
    Tvorogova MG; Titov VN; Sanfirova VM
    Farmakol Toksikol; 1982; 45(4):48-51. PubMed ID: 7128784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.
    Levy RI; Fredrickson DS; Stone NJ; Bilheimer DW; Brown WV; Glueck CJ; Gotto AM; Herbert PN; Kwiterovich PO; Langer T; LaRosa J; Lux SE; Rider AK; Shulman RS; Sloan HR
    Ann Intern Med; 1973 Jul; 79(1):51-8. PubMed ID: 4578640
    [No Abstract]   [Full Text] [Related]  

  • 20. Etofibrate therapy and effect of added low-dose cholestyramine in patients with combined hyperlipidaemia.
    Krüger B
    Int J Clin Pharmacol Res; 1994; 14(5-6):177-83. PubMed ID: 7672874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.